Pharmosa Biopharm Inc. (TPEX: 6875)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.20
-0.80 (-1.48%)
Dec 19, 2024, 1:30 PM CST

Pharmosa Biopharm Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-292.938.46-266.51-256.48-181.7
Depreciation & Amortization
26.5323.3212.711.7910.62
Other Amortization
---0.01-
Loss (Gain) on Equity Investments
-3.62-5.5-3.93-0.66-4.63
Stock-Based Compensation
3.50.870.5915.044
Other Operating Activities
-4.56--0.02-0.02-
Change in Accounts Receivable
18.06-1.180.03-0.14-0.15
Change in Inventory
-2.51-21.91---
Change in Accounts Payable
-8.310.59-2-0.77
Change in Other Net Operating Assets
-8.9737.79-1.19-9.05-8.83
Operating Cash Flow
-265.5742.42-258.31-237.51-181.45
Capital Expenditures
-189.27-81.46-10.16-3.06-7.05
Sale (Purchase) of Intangibles
-0.38-0.01-0.03-0.19-
Other Investing Activities
-6.78-12.380.0281.99
Investing Cash Flow
-1,065-93.84-10.174.75-5.07
Short-Term Debt Issued
----161
Long-Term Debt Issued
----9.5
Total Debt Issued
----170.5
Short-Term Debt Repaid
----61-165
Long-Term Debt Repaid
--14.22-15.9-26.34-33.99
Total Debt Repaid
-22.77-14.22-15.9-87.34-198.99
Net Debt Issued (Repaid)
-22.77-14.22-15.9-87.34-28.48
Issuance of Common Stock
963.26367.18495.42367.02637.29
Other Financing Activities
-----12
Financing Cash Flow
940.49352.97479.52279.68596.81
Foreign Exchange Rate Adjustments
000.01--
Net Cash Flow
-390.52301.55211.0546.93410.29
Free Cash Flow
-454.84-39.04-268.47-240.57-188.5
Free Cash Flow Margin
-900.31%-12.41%---
Free Cash Flow Per Share
-3.68-0.34-2.72-2.83-3.96
Cash Interest Paid
3.062.860.651.213.86
Levered Free Cash Flow
-369.47-50.37-165.23-135.95-
Unlevered Free Cash Flow
-367.56-48.59-164.83-135.19-
Change in Net Working Capital
6.16-10.46-1.78-3.17-
Source: S&P Capital IQ. Standard template. Financial Sources.